Partners
WP Lead Beneficiaries
Our Partners
Latvia
Austria
Belgium
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
(CA) LU University of Latvia
(AE) CDPC The Centre of Disease Prevention and Control of Latvia
(AE) PSCUH Pauls Stradins Clinical University Hospital
(AE) RSU Riga Stradins university
(CA) GÖG Austrian National Public Health Institute
(AE) UWK Universität für Weiterbildung Krems
(AE) WGF (MA24) Wiener Gesundheitsfonds (as part of Magistratsabteilung 24)
(AE) CCIV Competence Center Integrierte Versorgung
(AE) UMIT TIROL UMIT TIROL – Private Universität für Gesundheitswissenschaften und -technologie GmbH
(CA) Sciensano Sciensano
(AE) BCR Belgian Cancer Register
(AE) CvKO Centrum voor KankerOpsporing vzw
(CA) CIPH / HZJZ Croatian Institute of Public Health (Hrvatski zavod za javno zdravstvo)
(AE) KBC Zagreb University Hospital Centre Zagreb (Klinički bolnički centar Zagreb)
(CA) MOH CY MINISTRY OF HEALTH CYPRUS
(AE) UCY UNIVERSITY OF CYPRUS
(CA) ÚZIS Institute of Health Information and Statistics of the Czech Republic
(CA) SST Danish Health Authority
(AE) RSYD Southern Region of Denmark
(CA) NIHD National Institute for Health Development
(AE) UT University of Tartu
(CA) THL Finnish Institute of Health and Welfare
(AE) – Cancer Society of Finland (incl. Finnish Cancer Registry)
(CA) INCa Institut National du Cancer
(AE) Unicancer
(AE) AP-HP Assistance Publique – Hôpitaux de Paris
(AE) HDH Health Data Hub
(AE) FHF Fédération Hospitalière de France (FHF) Cancer
(AE) SPLF Société de Pneumologie de Langue Française
(AE) Hospices Civiles de Lyon
(AE) SFR Société française de Radiologie
(AE) AFU Urofrance – Association française d’urologie
(AE) CHU De Toulouse
(AE) REFLIS Réseau francophone de littératie en santé
(CA) RKI Robert Koch Institute – RKI, German Centre for Cancer Registry Data
(AE) DKG “German Cancer Society Deutsche Krebsgesellschaft (DKG)”
(CA) MoH Hellenic Ministry of Health – General Directorate of Public Health and Quality of Life – Directorate of Public and Environmental Health – Unit of Non-transmissible Diseases and Nutrition
(AE) 6th YPE DIOIKISI 6IS YGEIONOMIKIS PERIFEREIAS PELOPONNISOU KAI IONION NISON IPEIROU KAI DYTIKHS ELLADAS
(CA) Koranyi Koranyi National Institute for Pulmonology
(AE) NPHC (in Hungarian: NNK) National Center for Public Health and Pharmacy
(CA) Primary Health Care of the Capital Area Primary Health Care of the Capital Area in Iceland
(AE) Directorate of Health Directorate of Health
(CA) DoH The Department of Health
(AE) HSE Health Service Executive
Italy
Lithuania
Moldova
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
Ukraine
(CA) ISPRO ISTITUTO PER LO STUDIO, LA PREVENZIONE E LA RETE ONCOLOGICA
(AE) ISS Istituto Superiore di Sanità
(AE) MINSAL MINISTERO DELLA SALUTE
(AE) ASL TA ASL Taranto
(AE) ITGPII IRCCS Istituto Tumori “Giovanni Paolo II”
(AE) AUSLRE AUSL-IRCCS di Reggio Emilia
(AE) MaR Regione Marche
(AE) CPO AOU Città della Salute e della Scienza di Torino
(AE) PROMIS PROMIS
(AE) IRFMN Istituto di Ricerche Farmacologiche Mario Negri IRCCS
(AE) UNICATT Università Cattolica del Sacro Cuore
(AE) INT Fondazione Istituto nazionale dei Tumori IRCCS
(AE) LoR Regione Lombardia
(AE) Provincia autonoma PROVINCIA AUTONOMA DI BOLZANO – ALTO ADIGE
(CA) SAM LT MINISTRY OF HEALTH OF THE REPUBLIC OF LITHUANIA
(AE) SANTAROS LT VILNIUS UNIVERSITY HOSPITAL SANTAROS KLINIKOS
(AE) LSMUKK LT Hospital of Lithuanian University of Health Sciences Kauno Klinikos
(CA) PMSI IO PMSI Institute of Oncology
(CA) MFH MINISTRY FOR HEALTH
(CA) RIVM National Institute for Public Health and the Environment
(AE) MoH Ministry of health, welfare and sport
(AE) EMC Erasmus MC
(AE) RUMC Radboud UMC
(CA) Hdir The Norwegian Directorate of Health
(AE) OUS Oslo University Hospital
(CA) MSCI Maria Sklodowska-Curie National Research Institute of Oncology
(CA) DGS Direção-Geral da Saúde/ Directorate-General of Health
(CA) NIPH National Institute of Public Health
(AE) NCMHFAD National Center for Mental Health and the Fight Against Drugs
(AE) Iasi RIO Iasi Regional Institute of Oncology
(AE) FCI Fundeni Clinical Institute
(AE) IOCN The Oncology Institute “Prof. Dr. Ion Chiricuta” Cluj-Napoca
(CA) MoH SK Ministry of Health of the Slovak Republic
(AE) NOI National Oncology Institute
(CA) OI LJ Institute of Oncology Ljubljana
(AE) NIJZ NATIONAL INSTITUTE OF PUBLIC HEALTH
(CA) ICO Institut Català d’Oncologia
(AE) BIOSISTEMAK Instituto de Investigación en Sistemas de Salud
(AE) FISABIO Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
(AE) IACS Instituto Aragonés de Ciencias de la Salud
(AE) IDIVAL Fundación Instituto de Investigación Marqués de Valdecilla
(AE) IMIM Fundació Institut Hospital del Mar d’Investigacions Mèdiques
(CA) SoS National Board of Health and Welfare
(AE) RCC Confederation of Regional Cancer Centres
(CA) PHC “State institution “Public Health Center of the Ministry of Health of Ukraine”
(AE) IU NAMSU Academician O.F. Vozianov Institute of Urology of the National Academy of Medical Sciences of Ukraine
(AE) NCI NATIONAL CANCER INSTITUTE
The general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.
This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959
